Bastiaan Buddingh

Bastiaan Buddingh’ is a nanomedicine expert with international training from Eindhoven University of Technology and UC Berkeley. He earned his PhD developing lipid- and polymer-based nano and microparticles, followed by research in emulsion-based drug delivery and microfluidics. He then joined a biotech start-up in Paris to develop diagnostic microparticles based on nanotechnology. Currently, Bastiaan is Principal Scientist and Business Development Director at Ardena, a leading CDMO with a strong track record in nanomedicines, where he helps advance investigational drugs to the clinic using his expertise in nanoparticles and bioconjugation strategies.